A Case of Hemophilia B with Recurrent Haemophilus Influenzae Pneumonia and Abnormalities of Lymphocyte Functions

We treated an 11-year-old boy with hemophilia B who had recurrent pneumonia due to Haemophilus influenzae and who showed profound immunological abnormalities compatible with AIDS-related complex (ARC). He had been frequently treated with prothrombin complex concentrates since early childhood. At 11...

Full description

Saved in:
Bibliographic Details
Published inThe Japanese Journal of Pediatric Hematology Vol. 1; no. 1-2; pp. 154 - 159
Main Authors TANAKA, Yoshito, FUJITA, Atsushi, SAKANO, Takashi, UEDA, Kazuhiro, KOBAYASHI, Masao, KITTAKA, Eishi, TANIGUCHI, Hiroshi
Format Journal Article
LanguageJapanese
Published THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY 30.05.1987
Subjects
Online AccessGet full text
ISSN0913-8706
1884-4723
DOI10.11412/jjph1987.1.154

Cover

More Information
Summary:We treated an 11-year-old boy with hemophilia B who had recurrent pneumonia due to Haemophilus influenzae and who showed profound immunological abnormalities compatible with AIDS-related complex (ARC). He had been frequently treated with prothrombin complex concentrates since early childhood. At 11 years of age, he started to have recurrent pneumonia due to Haemophilus influenzae and abnormalities of lymphocyte functions. He was admitted to hospital six times over one year due3 to pneumonia with high fever and cough. At the time of these admissions, H. influenzae was always isolated from his sputum. Abnormal immunological findings were as follows : marked decrease of the number of OKT 4-positive cells, OKT 4/8 ratio, Tac-positive cells, and interleukin-2 production, absence of delayed-type hypersensitivity and diminished lymphocyte blastogenesis and immunoglobulin production as stimulated by pokeweed mitogen. Furthermore, a decrease of Leu 11-positive cells and depletion of natural killer cell activity were found. Serum human immunodeficiency virus antibody was positive by ELISA and Western Blot. A careful evaluation of clinical symptoms and immunological studies are necessary in hemophiliacs who receive long-term treatment with commercial coagulation factor concentrates.
ISSN:0913-8706
1884-4723
DOI:10.11412/jjph1987.1.154